On March 2, 2021 TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, reported that the Company’s management team will be presenting at the following virtual investor conferences (Press release, Taiwan Liposome Company, MAR 2, 2021, View Source [SID1234575954]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

HC Wainwright & Co Global Life Sciences Conference (March 9-10, 2021)
Presentation: on-demand starting 7am ET, Tuesday, March 9, 2021

Oppenheimer 31st Annual Healthcare Conference (March 16-17, 2021)
Presentation: 8am ET, Wednesday, March 17, 2021

The management team will also be participating in one-on-one meetings during the conference. The corporate presentation will be available on the TLC website at www.tlcbio.com in the Investors section, under News & Events.